Roche (ROG.SW) Financial Analysis & Valuation | Quarter Chart

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunolog... more
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, ... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$317.41BExchangeSIX
SectorHealthcareIndustryDrug Manufacturers - General
CountryCHCEOThomas Schinecker
IPO Date1995-08-03CAGR3.44%
Employees103,249Websitewww.roche.com
Div. Yield2.94%Payout Ratio35%
Buy Back Yield0.73%Total Yield3.67%
ROG.SW chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$357.38BP/E Ratio20.11
Forward P/E—PEG Ratio—
P/S Ratio4.31P/B Ratio7.85
P/CF Ratio17.95P/FCF Ratio22.34
EPS$19.83EPS Growth 1Y-11.31%
EPS Growth 3Y-5.39%EPS Growth 5Y24.89%
Revenue Growth 1Y1.57%Gross Margin0.74%
Operating Margin0.31%Profit Margin0.21%
ROE0.41%ROA0.13%
ROCE0.26%Current Ratio1.38
Quick Ratio1.12Cash Ratio0.2
Debt/Equity0.98Interest Coverage14.28
Altman Z Score5.55Piotroski Score7

View Roche financial charts →

Roche (ROG.SW) valuation & financials

Roche (ROG.SW) has a market capitalization of 317.41B CHF and trades at a price-to-earnings ratio of 20.1. It operates in the Healthcare sector (Drug Manufacturers - General).

Roche's revenue grew +1.6% over the last year.

Roche's next earnings report is scheduled for January 29, 2026; analysts estimate EPS of 11.03 CHF.

📈 Analysts estimate ROG.SW EPS of 11.03 CHF for the upcoming quarter. See Roche revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Roche (ROG.SW) — frequently asked questions

When does Roche (ROG.SW) report earnings next?

Roche is expected to report earnings on January 29, 2026. Analysts estimate EPS of 11.03 CHF.

What is Roche's market cap?

Roche (ROG.SW) has a market capitalization of 317.41B CHF.

What is ROG.SW's P/E ratio?

Roche trades at a price-to-earnings ratio of 20.1, with trailing twelve-month EPS of 19.83 CHF.

How fast is Roche growing?

Roche's revenue grew +1.6% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Novartis (NVS)

Roche revenue & earnings charts →